Nishith Desai Associates: Deal Corner
Posted by By nishithadmin at 30 April, at 16 : 30 PM Print
Warning: count(): Parameter must be an array or an object that implements Countable in /web/qlc/nishith.tv/htdocs/wp-content/themes/Video/single_blog.php on line 46
Warning: count(): Parameter must be an array or an object that implements Countable in /web/qlc/nishith.tv/htdocs/wp-content/themes/Video/single_blog.php on line 52
SERIES B INVESTMENT IN MFINE – A HEALTH-TECH STARTUP
DEAL BRIEF
SBI (through its investment vehicles in Japan and Singapore), Beenext, along with other investors led the Series B investment of approx. USD 17 million into NovoCura Tech Health Services Private Limited (doing business as ‘mfine’), a health-tech startup based out of Bengaluru, India. Mfine was founded in 2017 by Ashutosh Lawania (co-founder of Myntra) and Prasad Kompalli (former chief business officer of Myntra).
SBI is an internet-based financial conglomerate from Japan and Beenext is a leading venture capital firm from Singapore. Press coverage, relating to the transaction, is available at the Hindu Business Line and Livemint.
OUR ROLE
We, at Nishith Desai Associates,acted as legal counsels to SBI and Beenext. We advised them on the legal, regulatory and strategic aspects of the transaction.
Legal500 Asia-Pacific 2019: Tier 1 for Dispute Resolution, International Tax, Investment Funds, Labour & Employment, TMT and Corporate M&A
Chambers and Partners Asia Pacific 2019: Band 1 for Labour & Employment, Lifesciences, Tax and TMT
AsiaLaw 2019: Ranked ‘Outstanding’ for Technology, Labour & Employment, Private Equity, Regulatory and Tax
IFLR 1000 Asia Pacific 2019: Tier 1 for TMT and Private Equity
RSG-Financial Times: India’s Most Innovative Law Firm (2014, 2015 & 2017)
RSG-FT Awards (London) 2016: Asia Pacific’s Most Innovative Law Firm
Merger Market 2018: Fastest growing M&A practice
Benchmark Litigation Asia Pacific 2018: Tier 1 for Tax
IDEX: Tier 1 for Dispute Resolution
Asian Mena Counsel’s In-House Community Firms survey 2018- NDA voted as the only firm from India to excel in the Life Sciences sector
The Most Innovative Law Firm in Asia-Pacific